• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

How does Otezla do it?

Looks like the Otezla miracle is OVER! BMY is going to buy them and they couldn't sell pussy on a troop ship. They will run off the Otezla reps who are ballers and kill the product. We win!